↓ Skip to main content

Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis

Overview of attention for article published in Frontiers in Pharmacology, July 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
24 X users

Citations

dimensions_citation
436 Dimensions

Readers on

mendeley
408 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Published in
Frontiers in Pharmacology, July 2017
DOI 10.3389/fphar.2017.00461
Pubmed ID
Authors

Kelly L Walton, Katharine E Johnson, Craig A Harrison

X Demographics

X Demographics

The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 408 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 408 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 71 17%
Student > Master 45 11%
Student > Bachelor 45 11%
Researcher 42 10%
Student > Doctoral Student 21 5%
Other 54 13%
Unknown 130 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 104 25%
Medicine and Dentistry 53 13%
Agricultural and Biological Sciences 29 7%
Pharmacology, Toxicology and Pharmaceutical Science 21 5%
Immunology and Microbiology 13 3%
Other 42 10%
Unknown 146 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2020.
All research outputs
#2,571,572
of 25,837,817 outputs
Outputs from Frontiers in Pharmacology
#1,086
of 20,002 outputs
Outputs of similar age
#46,119
of 327,704 outputs
Outputs of similar age from Frontiers in Pharmacology
#26
of 257 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,002 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,704 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 257 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.